
Deferral of percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation (PRO-TAVI): an investigator-initiated, multicentre, open-label, non-inferiority, randomised controlled trial
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxNdVpKN0NGc3d4TzROemtQRUY2RUlvWU5HR2tlTlVLblBWV184N1dSS3FrRTdsU0NmNFJOVm5qVVRKM1Z5alpLdVVmbTBrVmN6NEV5aFo0TFdXRUVRS0JBc2NYU21IUVo2SS1jZ2p4OHpJWVFYQTZGZkd0RS1FemtTaFNKTU1MT3VWR09F?oc=5" target="_blank">Deferral of percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation (PRO-TAVI): an investigator-initiated, multicentre, open-label, non-inferiority, randomised controlled trial</a>&nbsp;&nbsp;<font color="#6f6f6f">The Lancet</font>
